Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Why Record-Shattering Heat Has Scientists On Edge
The latest calculations from several science agencies showing Earth obliterated global heat records last year may seem scary. But scientists worry that what’s behind those numbers could be even worse.
IRS says it collected $360 million more from rich tax cheats as its funding is threatened yet again
Along with the $122 million from delinquent millionaires in October, nearly half a billion dollars in back taxes from rich tax cheats has been collected.
How Zoomcar is Expanding the Car-Sharing Universe
Greg Moran, CEO of Zoomcar, joined Cheddar to talk about the growth of the car-sharing platform, the company's recent debut on the NASDAQ, and its continued work in emerging markets.
The Unofficial Kickoff to Earnings Season
At Friday's market open, Kristen Scholer chats inflation data, bank earnings, and the unofficial start of earnings season.
Say Goodbye to These Outdated Travel Trends in 2024
Here are travel industry fads we hope to see go, and what we’d like to see in its place this year.
Uh, Who Ordered These Spiders and Roaches?
eBay to pay $3 million after its employees subjected Massachusetts couple to “pure hell” harassment campaign
FAA Opens Official Investigation Into Boeing Safety Standards
Federal officials are investigating Boeing's oversight of production of a panel that blew off a jetliner in midflight last week.
Bitcoin ETFs Open For Trading. Here are the Tickers to Watch
Bitcoin ETFs will begin trading for the first time today. Here are the tickers to watch.
Inflation Creeps Up, Fueled by Higher Rents and Food Prices
Higher rents and food prices boosted overall U.S. inflation in December, a sign that the Federal Reserve's drive to slow inflation to its 2% target will likely remain a bumpy one.
